source
- FDA reverses stance, allows UniQure to file for accelerated approval of Huntington’s gene therapy AMT-130The Food and Drug Administration has changed its earlier position and now permits UniQure to submit a marketing application for its experimental Huntington’s disease gene therapy, AMT-130. The age…
- RFK Jr. announces $700 million mental-health funding, experts say money is from existing grantsRFK Jr. announced a $700 million package aimed at mental health and addiction services, with a particular focus on addressing homelessness linked to severe, untreated mental illness. Behavioral he…